NT_1170x120_1-11-18

HSAs

Law promises big O-T-C savings

Law promises big O-T-C savings

NEW YORK — A provision in the Coronavirus Aid, Relief and Economic Security (CARES) Act, which Congress passed and President Trump signed into law in March, offers a potential boon to consumers and retailers, according to Glaxo­Smith­Kline (GSK), which is one of the largest providers of over-the-counter medications in the world. The provision in the

Year of opportunity for OTC medicines

Year of opportunity for OTC medicines

The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome a new American president and Congress, the country is waiting to see how the regulatory and legislative landscape will evolve. But I am certain that one thing will not change: the continued importance of over-the-counter

CHPA backs bill to repeal FSA restriction on OTCs

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has endorsed the Restoring Access to Medicines Act of 2015 (H.R. 1270), which would make it easier for consumers to use medical savings account funds to buy over-the-counter medicines. CHPA said Thursday that the bill, introduced in the House of Representatives by Reps. Lynn Jenkins (R., Kan.)